Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biogen Deploys Spotfire DecisionSite to Deliver Advanced Analytical Capabilites.


Business/Technology/Biotechnology Editors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 9, 2001

Leading Biotechnology Company Partners with Spotfire to Accelerate

Breakthrough Therapeutic Discoveries

Spotfire(R) today announced that Biogen has adopted Spotfire DecisionSite to accelerate the drug discovery and development process. The partnership will enhance Biogen's core research strength, the ability to rapidly ascertain new drug candidates, by enabling scientists and researchers to access, analyze and share data - collaborating across teams, departments and geographies.

"In order to maintain our industry leadership, it is critical that we set aggressive, ever-increasing performance standards. This includes empowering every individual to make faster, more effective decisions," said Dr. Rainer Fuchs, Senior Director, Research Informatics Same as information technology and information systems. The term is more widely used in Europe. , Biogen. "We recognize that one of the key next challenges in the genome race is to equip decision makers with an integrated user experience into genomics, chemistry, and screening data. Spotfire DecisionSite gives us this ability, resulting in a substantial competitive advantage."

"As one of the oldest, independent biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, Biogen has an extraordinary depth of experience in the research and discovery of new drug candidates," said Dr. Christopher Dr. John R. Christopher, known popularly as "Dr. Christopher" was one of very few nationally prominent doctors of herbal medicine of the middle third of the 20th century, a "dark ages" of herbalism and was responsible for the herbal renaissance of the 1960s.  Ahlberg, founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Spotfire. "We're honored to partner with one of the driving forces behind the emergence of next generation biopharmaceutical drugs and are happy to assist Biogen in its quest for Verb 1. quest for - go in search of or hunt for; "pursue a hobby"
quest after, go after, pursue

look for, search, seek - try to locate or discover, or try to establish the existence of; "The police are searching for clues"; "They are searching for the
 more efficient identification of breakthrough molecules and targeted drug design."

About Spotfire(R)

Spotfire, Inc. is a leading provider of eAnalytic applications and services that put the power of decision-making at the center of its customers' businesses. Spotfire's solutions enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes Presented below is a list of topics on decision-making and decision-making processes:

| width="" align="left" valign="top" |
  • Choice
  • Cybernetics
  • Decision
  • Decision making
  • Decision theory


| width="" align="left" valign="top" |
 by advancing both individual and networked analysis. More than 350 customers and over 16,000 subscribers use Spotfire products worldwide. The company maintains U.S. headquarters in Cambridge, Mass. and European headquarters in Goteborg, Sweden. Additional information can be found at http://www.spotfire.com.

About Biogen

Biogen, Inc., winner of the U.S. National Medal of Technology, is a biopharmaceutical company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. Headquartered in Cambridge, MA, the Company's revenues are generated from international sales of AVONEX(R) (Interferon beta-1a interferon beta-1a

Avonex, Rebif

Pharmacologic class: Biological response modifier

Therapeutic class: Antiviral, immunoregulator

Pregnancy risk category C

Action

) for treatment of relapsing forms of multiple sclerosis, and from the worldwide sales by licensees of a number of products, including alpha interferon and hepatitis B vaccines hepatitis B vaccine
n. Abbr. HB
A vaccine prepared from the inactivated surface antigen of the hepatitis B virus and used to immunize against hepatitis B.
 and diagnostic products. Biogen's research and development activities are focused on novel products to treat inflammatory and autoimmune diseases Autoimmune diseases
A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs.

Mentioned in: Complement Deficiencies, Premature Menopause
, neurological diseases, cancer, fibrosis and congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. . The Company maintains active clinical research programs in protein therapeutics, small molecules, genomics and gene therapy. For copies of press releases and additional information about the Company, please consult Biogen's Homepage on the World Wide Web at http://www.biogen.com

Spotfire is a registered trademark and DecisionSite is a trademark of Spotfire, Inc. All other names or marks may be registered trademarks or trademarks of their respective owners and are hereby acknowledged.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 9, 2001
Words:488
Previous Article:Fuji Photo and Stratasys Sign R&D Agreement.
Next Article:Spotfire Expands DecisionSite Product Family With Role-Based Application for New Product Development.
Topics:



Related Articles
Spotfire Expands DecisionSite Product Family With Role-Based Application for New Product Development.
Spotfire and Micromass to Speed Analysis of Chemical and Proteomics Data; Will Link Spotfire DecisionSite With Micromass MassLynx Mass Spectrometry...
Spotfire Ships DecisionSites to Accelerate Decision-Making Functions in Pharmaceutical, Energy/Oil and Gas and Manufacturing Industries.
Procter & Gamble, Biogen, Anadarko and Others Gain Discovery Advantage With Spotfire DecisionSite.
Spotfire First to Extend Analytics to Any Product Lifecycle Process.
Infinity Pharmaceuticals Chooses Spotfire to Support Analysis in Drug Discovery Process; Interactive Analytics Provides Unique Value for Infinity.
Spotfire Announces Web Services Support for DecisionSite to Inject Analytics Into Business Processes.
Microbia Selects Spotfire DecisionSite To Speed Drug Discovery Decision Making.
SCIENTISTS DEPEND ON SHARED DATA IN QUEST FOR CURES.
Cubist Deploys Spotfire to Gain an Information Advantage in Sales & Marketing.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles